CV Sciences Inc (CVSI)

[Wolf-man jack]

ALL YQU NEED TO KNOW ABOUT CV SCIENCES AND THE CBD FUTURE MARKET

May 14, 2026

EDGAR Company Search Results

https://www.sec.gov/cgi-bin/browse-edgar?company=CV+Sciences+&match=&CIK=Cvsi&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Q1- 2026 Earnings Conference Call Headlines Transcript

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177607002

Q1- 2026 Quarterly Results

https://ir.cvsciences.com/sec-filings-email/content/0001193125-26-226702/cvsi-20260331.htm

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177607625

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177607945

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177612006

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177612049


BREAKING NEWS FEBRUARY 13, 2026

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177295726

CV Sciences, Inc. Achieves Industry’s First Hemp Extract GRAS Self-Affirmation
Download as PDFSeptember 10, 2018

https://ir.cvsciences.com/press-releases/detail/85/cv-sciences-inc-achieves-industrys-first-hemp-extract

CV SCIENCES
https://www.cvsciences.com/

ELEVATED SOFTGELLS - CV SCIENCES WHOLLY OWNED SUBSIDIARY
https://elevatedsoftgels.com/

CULTURED FOODS - CV SCIENCES WHOLLY OWNED SUBSIDIARY
https://culturedfoods.eu

LUNAR FOX FOOD COMPANY - CV SCIENCES WHOLLY OWNED SUBSIDIARY
https://www.lunarfoxfoods.com


BREAKING NEWS FEBRUARY 12, 2026

Corn_kernel
Thursday, February 12, 2026 1:17:16 PM

CBD Regulatory & Macro Outlook panel, hosted by Pablo Zuanic on X with guests: Joseph Dowling, CEO, CV_Sciences: Jared Stanley, Co-founder & Board Member, Charlottesweb: and John Harloe, General Counsel, CBDistillery.

LINK ¥
https://x.com/420Odysseus/status/202168892642818490


Saturday, February 14, 2026 10:26:01 AM

It’s all laid out in the PR, coming soon, expect PR announcing…

“The acquisition creates opportunity for importation of these specialty foods to the U.S. AND ESTABLISHES A EUROPEAN BASE OF OPERATIONS FOR THE SALE AND DISTRIBUTION OF +PlusCBD PRODUCTS, OPENING DOORS TO NUMEROUS NEW RETAIL AND DISTRIBUTOR PARTNERS.”

Enjoy Reading:
https://ir.cvsciences.com/press-releases/detail/219/cv-sciences-inc-acquires-cultured-foods-to-enter

https://culturedfoods.eu/

https://ir.cvsciences.com/press-releases/detail/228/cv-sciences-launches-plushlth-a-new-line-of

https://ir.cvsciences.com/press-releases/detail/224/cv-sciences-inc-acquires-elevated-softgels-a-flexible

Enjoy reading:
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-food-agency-sets-safe-consumption-level-hemp-derived-cbd-2026-02-09/

https://i.etsystatic.com/42055322/r/il/c891da/7296956080/il_1588xN.7296956080_n527.jpg



Ai Generated

Yes, the Medicare Advantage pilot program for CBD is likely to involve more than one company. While Charlotte's Web has been announced as a premier partner for the program, other industry players are actively positioning themselves to participate in this initiative.

Here are the key details regarding participants and the scope of the program:

Key Participant (Charlotte's Web): The company has announced its partnership with the Center for Medicare and Medicaid Innovation (CMMI) to provide hemp-derived CBD products, specifically for senior oncology patients, beginning in early 2026.

Industry Positioned to Participate: Other companies, such as High Tide (through its brands NuLeaf Naturals and FAB CBD), are developing Medicare-aligned product categories in anticipation of participating in this new Medicare Advantage supplemental benefit. Additionally, CV Sciences, Inc. has stated it is "strongly positioned to participate" in the pilot program.

Regulatory Requirements: The program will require strict compliance and quality standards, which suggests that only companies with rigorous, audited, and compliant products (such as those with Good Manufacturing Practices) will likely be involved.

Structure: The initiative is designed to test how CBD fits into Medicare's financial and clinical structure, suggesting a, potentially, multi-vendor approach to evaluate different products.
The program is expected to launch as early as April 2026, offering up to $500 in annual coverage for eligible seniors.